Mingbo Su
Impact in
- Organic Chemistry top 5%
- Synthesis and biological activity
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Metabolism, Diabetes, and Cancer
- Epigenetics and DNA Methylation
Papers in
-
- Diabetes Treatment and Management 10
- Natural Antidiabetic Agents Studies 8
-
- Histone Deacetylase Inhibitors Research 17
- Protein Degradation and Inhibitors 4
- Epigenetics and DNA Methylation 3
- Co-authors
- Jia Li (32 shared papers)Yubo Zhou (16 shared papers)Fajun Nan (7 shared papers)Wei Ping Lu (8 shared papers)Yi Chen (6 shared papers)Li-Fang Yu (5 shared papers)Xuan Zhang (5 shared papers)Jing-Ya Li (4 shared papers)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry (6 papers)Journal of Medicinal Chemistry (5 papers)ACS Medicinal Chemistry Letters (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Mingbo Su
46 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 76
- Organic Chemistry 366
- Molecular Biology 675
- Aging 17
- Computational Theory and Mathematics 123
- Endocrinology, Diabetes and Metabolism 123
Countries citing papers authored by Mingbo Su
This map shows the geographic impact of Mingbo Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingbo Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingbo Su more than expected).
Fields of papers citing papers by Mingbo Su
This network shows the impact of papers produced by Mingbo Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingbo Su. The network helps show where Mingbo Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingbo Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 169 | |
| 2 | 2008 | 142 | |
| 3 | 2012 | 92 | |
| 4 | 2015 | 73 | |
| 5 | 2013 | 64 | |
| 6 | 2013 | 63 | |
| 7 | 2013 | 54 | |
| 8 | 2016 | 53 | |
| 9 | 2013 | 44 | |
| 10 | 2016 | 42 | |
| 11 | 2022 | 38 | |
| 12 | 2014 | 37 | |
| 13 | 2020 | 36 | |
| 14 | 2017 | 35 | |
| 15 | 2019 | 35 | |
| 16 | 2014 | 34 | |
| 17 | 2013 | 32 | |
| 18 | 2014 | 27 | |
| 19 | 2022 | 27 | |
| 20 | 2019 | 26 |
About Mingbo Su
Mingbo Su is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Organic Chemistry, Oncology and Hematology, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (17 papers), Synthesis and biological activity (13 papers), Diabetes Treatment and Management (10 papers), Natural Antidiabetic Agents Studies (8 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (4 papers), Computational Drug Discovery Methods (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Organic Chemistry (366 citations), Molecular Biology (675 citations), Aging (17 citations), Computational Theory and Mathematics (123 citations) and Endocrinology, Diabetes and Metabolism (123 citations). Mingbo Su has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Jia Li, Yubo Zhou, Fajun Nan, Wei Ping Lu, Yi Chen, Li-Fang Yu, Xuan Zhang, Jing-Ya Li, Yi Zang and Tao Pang. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.